These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 6275779)

  • 21. Pharmacokinetic study of cefmenoxime (SCE 1365-CMX) in healthy adults.
    Fourtillan JB; Bryskier A; Mignot A; Borsa F; Humbert G
    Am J Med; 1984 Dec; 77(6A):28-31. PubMed ID: 6097120
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biliary excretion of amoxycillin and ceftriaxone after intravenous administration in man.
    Maudgal DP; Maxwell JD; Lees LJ; Wild RN
    Br J Clin Pharmacol; 1982 Aug; 14(2):213-7. PubMed ID: 6285946
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Absolute bioavailability of ceftriaxone after intramuscular administration to healthy volunteers.
    Delsignore R; Baroni CM; Crotti G; Mineo F; Butturini U; Ascalone V; Cisternino M
    Chemotherapy; 1983; 29(3):157-62. PubMed ID: 6307601
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intramuscular and intravenous pharmacokinetics of cefmenoxime, a new broad-spectrum cephalosporin, in healthy subjects.
    Granneman GR; Sennello LT; Steinberg FJ; Sonders RC
    Antimicrob Agents Chemother; 1982 Jan; 21(1):141-5. PubMed ID: 6282203
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Crossover study of the pharmacokinetics of ceftriaxone administered intravenously or intramuscularly to healthy volunteers.
    Meyers BR; Srulevitch ES; Jacobson J; Hirschman SZ
    Antimicrob Agents Chemother; 1983 Nov; 24(5):812-4. PubMed ID: 6318657
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of Ro 13-9904, a broad-spectrum cephalosporin.
    Seddon M; Wise R; Gillett AP; Livingston R
    Antimicrob Agents Chemother; 1980 Aug; 18(2):240-2. PubMed ID: 7447404
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kinetic disposition of intravenous ceftriaxone in normal subjects and patients with renal failure on hemodialysis or peritoneal dialysis.
    Ti TY; Fortin L; Kreeft JH; East DS; Ogilvie RI; Somerville PJ
    Antimicrob Agents Chemother; 1984 Jan; 25(1):83-7. PubMed ID: 6322683
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elimination kinetics of cefotaxime and desacetyl cefotaxime in patients with renal insufficiency and during hemodialysis.
    Ohkawa M; Okasho A; Motoi I; Tokunaga S; Shoda R; Kawaguchi S; Sawaki M; Shimamura M; Hirano S; Kuroda K; Awazu S
    Chemotherapy; 1983; 29(1):4-12. PubMed ID: 6299656
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of ceftriaxone in subjects with renal insufficiency.
    Kowalsky SF; Echols RM; Parker MA
    Clin Pharm; 1985; 4(2):177-81. PubMed ID: 3987216
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of ceftriaxone after intravenous infusion and intramuscular injection.
    Scully BE; Fu KP; Neu HC
    Am J Med; 1984 Oct; 77(4C):112-6. PubMed ID: 6093511
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics and dose proportionality of cefpimizole in normal humans after intramuscular administration.
    Lakings DB; Novak E; Friis JM; Lunan CM; Paxton LM
    Antimicrob Agents Chemother; 1986 Feb; 29(2):271-7. PubMed ID: 3717932
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of ceftriaxone in patients with typhoid fever.
    Acharya G; Crevoisier C; Butler T; Ho M; Tiwari M; Stoeckel K; Bradley CA
    Antimicrob Agents Chemother; 1994 Oct; 38(10):2415-8. PubMed ID: 7840580
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative pharmacokinetics of YM-13115, ceftriaxone, and ceftazidime in rats, dogs, and rhesus monkeys.
    Matsui H; Komiya M; Ikeda C; Tachibana A
    Antimicrob Agents Chemother; 1984 Aug; 26(2):204-7. PubMed ID: 6091536
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The pharmacokinetics of cefotaxime and ceftriaxone in renal and hepatic dysfunction.
    Wise R; Wright N
    Infection; 1985; 13 Suppl 1():S145-50. PubMed ID: 4055047
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of Rocephin, a highly active new cephalosporin with an exceptionally long biological half-life.
    Stoeckel K
    Chemotherapy; 1981; 27 Suppl 1():42-6. PubMed ID: 7249794
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phase I study of ceftizoxime, a new cephalosporin. Single-dose study.
    Nakashima N; Suzuki K; Hashimoto H; Nishijima K
    J Clin Pharmacol; 1981 Oct; 21(10):388-95. PubMed ID: 6273456
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Single-dose ceftriaxone pharmacokinetics in pediatric patients with central nervous system infections.
    Chadwick EG; Yogev R; Shulman ST; Weinfeld RE; Patel IH
    J Pediatr; 1983 Jan; 102(1):134-7. PubMed ID: 6294263
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Single-dose ceftriaxone kinetics in functionally anephric patients.
    Stoeckel K; McNamara PJ; Hoppe-Seyler G; Blumberg A; Keller E
    Clin Pharmacol Ther; 1983 May; 33(5):633-41. PubMed ID: 6301740
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of cefotiam in humans.
    Rouan MC; Lecaillon JB; Guibert J; Modai J; Schoeller JP
    Antimicrob Agents Chemother; 1985 Feb; 27(2):177-80. PubMed ID: 3857018
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of cefodizime in patients with various degrees of renal failure.
    Loffreda A; Lampa E; Lucarelli C; Amorena M; Contaldi C; Calderaro V; Rossi F
    Chemotherapy; 1999; 45(1):1-7. PubMed ID: 9876203
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.